Research
Hormonal
Hummus consumption attenuates post-prandial blood glucose and insulin responses compared to carbohydrate-only foods, due to its low glycemic index and fat content slowing gastric emptying.
Pair hummus with high-carb foods like bread or crackers. The fat and fiber in hummus slow down digestion, resulting in a significantly lower blood sugar spike compared to eating the carbs alone.
GoodSupportsHIGH confidence
Post-prandial glucose responses were four times lower than that of white bread in a study of 10 healthy subjects consuming hummus. Blood glucose levels were significantly lower after 45 minutes when subjects were fed hummus with 25 g of available carbohydrates (in the form of white bread), as compared to 25 g of carbohydrates alone
Why this rating
Supported by intervention studies (10 subjects, 45 subjects) and mechanistic explanations.
Source
The Nutritional Value and Health Benefits of Chickpeas and Hummus
Taylor C. Wallace et al. · Nutrients · 2016
DOI 10.3390/nu8120766
narrative_reviewCited 251×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Substituting traditional hummus for energy-dense dips and spreads (e.g., mayonnaise, butter, sour cream) improves overall diet quality and nutrient density while reducing caloric, saturated fat, and sodium intake.Good
- Consumption of chickpeas and hummus is associated with lower body mass index (BMI), reduced waist circumference, and lower likelihood of obesity compared to non-consumers.Moderate
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →